Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06362226
PHASE1

Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management

Sponsor: Virginia Commonwealth University

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the effectiveness in using subcutaneous 5-FU/Kenalog \& topical Maxitrol Ophthalmic ointment as different therapeutic adjuncts in the prevention of pathologic remodeling after periorbital burns.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-02-28

Completion Date

2027-01

Last Updated

2026-01-16

Healthy Volunteers

No

Interventions

DRUG

Steroid/Antibiotic (Maxitrol)

Group one subjects receive topical maxitrol ophthalmic ointment twice daily for two weeks

DRUG

5-FU/Kenalog

Group two undergoes treatment with a subcutaneous injection of a 5-fluorouracil (5-FU) and Kenalog (triamcinolone) combination (80/20 ratio, 0.3-0.5 mL per session) administered in four sessions, spaced two weeks apart, starting within 48 hours of hospital presentation